Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dipyridamole for acute respiratory distress syndrome
ChiCTR2300078059Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital, Anhui Medical University
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dipyridamole in acute respiratory distress syndrome (ARDS) (3 arms), sponsored by The First Affiliated Hospital, Anhui Medical University. Primary endpoint: All-cause mortality rate. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
dipyridamole
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on ChiCTR2300078059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078059.